|
FY2026
12 months to Aug 1, 2026
|
FY2025
12 months to Aug 2, 2025
|
FY2024
12 months to Aug 3, 2024
|
FY2023
12 months to Jul 29, 2023
|
FY2022
12 months to Jul 30, 2022
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Cash Flows from Operating Activities from Continuing Operations: | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash provided by operating activities from continuing operations: | |||||
| Change in inventory reserves | |||||
| Stock-based compensation expense | |||||
| Depreciation, amortization, and accretion | |||||
| Asset impairment | |||||
| Other | |||||
| Change in operating assets and liabilities: | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Income tax receivables | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Gift card liability | |||||
| Other liabilities | |||||
| Net cash provided by operating activities from continuing operations | |||||
| Cash Flows from Investing Activities from Continuing Operations: | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of property and equipment | |||||
| Purchases of securities available-for-sale | |||||
| Sales of securities available-for-sale | |||||
| Maturities of securities available-for-sale | |||||
| Net cash used in investing activities from continuing operations | |||||
| Cash Flows from Financing Activities from Continuing Operations: | |||||
| Proceeds from the exercise of stock options, net | |||||
| Payments for tax withholdings related to vesting of share-based awards | |||||
| Repurchase of common stock | |||||
| Other | |||||
| Net cash used in financing activities from continuing operations | |||||
| Net decrease in cash and cash equivalents from continuing operations | |||||
| Cash Flows from Discontinued Operations: | |||||
| Net cash used in operating activities from discontinued operations | |||||
| Net cash used in investing activities from discontinued operations | |||||
| Net cash used in financing activities from discontinued operations | |||||
| Net decrease in cash and cash equivalents from discontinued operations | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for income taxes | |||||
| Supplemental Disclosure of Non-Cash Investing and Financing Activities: | |||||
| Purchases of property and equipment included in accounts payable and accrued liabilities | |||||
| Capitalized stock-based compensation | |||||
Loading...